LEIGH PERREAULT
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism
- Where
- WESTMINSTER, CO
- NPI
- 1669562344
- Received
- $1,657,613 in 1,583 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 195 | $219,646 |
| 2024 | General payment | 256 | $225,826 |
| 2023 | General payment | 219 | $184,082 |
| 2022 | General payment | 249 | $264,930 |
| 2021 | General payment | 189 | $237,279 |
| 2020 | General payment | 191 | $205,763 |
| 2019 | General payment | 284 | $320,085 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Lilly USA, LLC | 571 | $495,926 | 2019–2025 |
| Novo Nordisk Inc | 380 | $483,498 | 2019–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 292 | $260,492 | 2019–2025 |
| SANOFI-AVENTIS U.S. LLC | 49 | $122,124 | 2019–2025 |
| AstraZeneca Pharmaceuticals LP | 86 | $75,311 | 2019–2022 |
| Bayer Healthcare Pharmaceuticals Inc. | 58 | $51,584 | 2021–2023 |
| Merck Sharp & Dohme LLC | 38 | $45,268 | 2019–2020 |
| Boehringer Ingelheim International GmbH | 36 | $42,730 | 2025 |
| Janssen Pharmaceuticals, Inc | 26 | $33,970 | 2019–2024 |
| Eli Lilly and Company | 33 | $31,483 | 2020–2025 |
| Novo Nordisk AS | 9 | $11,609 | 2021–2025 |
| Ascendis Pharma Endocrinology Inc | 2 | $3,540 | 2025 |
| Amarin Pharma, Inc. | 1 | $28 | 2019 |
| Amryt Pharma Holdings Ltd | 1 | $27 | 2023 |
| Mannkind Corporation | 1 | $17 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 599 | $1,174,061 |
| Consulting Fee | 79 | $276,757 |
| Travel and Lodging | 496 | $177,005 |
| Food and Beverage | 408 | $29,783 |
| Education | 1 | $5 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-26 | Ascendis Pharma Endocrinology Inc | $1,416 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Yorvipath Drug, Endocrinology | 2025 | |
| 2025-11-07 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-10-24 | Boehringer Ingelheim International GmbH | $5,085 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Boehringer Ingelheim International GmbH | $1,977 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Boehringer Ingelheim International GmbH | $1,600 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-24 | Boehringer Ingelheim International GmbH | $210 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-02 | Novo Nordisk Inc | $5,928 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $401 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $316 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-01 | Novo Nordisk Inc | $5,928 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-10-01 | Novo Nordisk Inc | $401 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-01 | Novo Nordisk Inc | $316 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-01 | Novo Nordisk Inc | $84 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $5,928 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $401 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $316 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $244 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $204 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $58 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-14 | Boehringer Ingelheim International GmbH | $6,540 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $1,175 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $831 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $293 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-14 | Boehringer Ingelheim International GmbH | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-26 | SANOFI-AVENTIS U.S. LLC | $79 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-08-22 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $29 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $19 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,150 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,740 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | $28 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-26 | Lilly USA, LLC | $146 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-06-26 | Lilly USA, LLC | $88 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-06-25 | Novo Nordisk Inc | $691 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $672 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $213 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $143 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $53 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $47 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $47 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $38 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $31 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $386 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-06-23 | Novo Nordisk AS | $2,325 | Consulting Fee | Cash or cash equivalent | Drug, Diabetes | 2025 | |
| 2025-06-23 | Novo Nordisk AS | $544 | Travel and Lodging | In-kind items and services | Drug, Diabetes | 2025 | |
| 2025-06-23 | Novo Nordisk AS | $174 | Food and Beverage | In-kind items and services | Drug, Diabetes | 2025 | |
| 2025-06-23 | Novo Nordisk AS | $62 | Travel and Lodging | In-kind items and services | Drug, Diabetes | 2025 | |
| 2025-06-22 | Eli Lilly and Company | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-20 | Novo Nordisk Inc | $103 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-10 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-06-08 | Novo Nordisk AS | $930 | Consulting Fee | Cash or cash equivalent | Drug, Diabetes | 2025 | |
| 2025-06-06 | Ascendis Pharma Endocrinology Inc | $2,124 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Yorvipath Drug, Endocrinology | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $4,068 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $4,068 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $1,116 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $312 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $296 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $70 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $58 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-19 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $8,486 | Consulting Fee | Cash or cash equivalent | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $631 | Travel and Lodging | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $506 | Food and Beverage | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $503 | Travel and Lodging | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $281 | Travel and Lodging | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $57 | Travel and Lodging | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-29 | Novo Nordisk Inc | $930 | Consulting Fee | Cash or cash equivalent | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-04-28 | Boehringer Ingelheim International GmbH | $1,290 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-28 | Lilly USA, LLC | $32 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $9,183 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $607 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $549 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $541 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $348 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Novo Nordisk Inc | $58 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-22 | Novo Nordisk Inc | $930 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-18 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-16 | Novo Nordisk Inc | $4,533 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-04-16 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-16 | Novo Nordisk Inc | $819 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-16 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Novo Nordisk Inc | $53 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-10 | Novo Nordisk Inc | $4,068 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-04-10 | Lilly USA, LLC | $1,650 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-10 | Novo Nordisk Inc | $531 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $173 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $141 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-09 | Lilly USA, LLC | $713 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-09 | Lilly USA, LLC | $423 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-09 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-09 | Lilly USA, LLC | $3 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $4,068 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $506 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $409 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-08 | Novo Nordisk Inc | $173 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $141 | Travel and Lodging | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-31 | Lilly USA, LLC | $28 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $58 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $30 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $17 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $12 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $11 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $472 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-03-24 | Boehringer Ingelheim International GmbH | $4,300 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-24 | Lilly USA, LLC | $2,362 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-24 | Boehringer Ingelheim International GmbH | $1,600 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-24 | Boehringer Ingelheim International GmbH | $90 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-24 | Boehringer Ingelheim International GmbH | $83 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-24 | Boehringer Ingelheim International GmbH | $42 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-24 | Boehringer Ingelheim International GmbH | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-18 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-18 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-18 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-18 | Lilly USA, LLC | $825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-18 | Lilly USA, LLC | $33 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-13 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-13 | Lilly USA, LLC | $825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-13 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Boehringer Ingelheim International GmbH | $3,870 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-12 | Boehringer Ingelheim International GmbH | $800 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-12 | Lilly USA, LLC | $763 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-12 | Lilly USA, LLC | $252 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-12 | Lilly USA, LLC | $174 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-12 | Boehringer Ingelheim International GmbH | $102 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-12 | Boehringer Ingelheim International GmbH | $61 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-12 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-11 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-11 | Eli Lilly and Company | $1,925 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-11 | Lilly USA, LLC | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $918 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-07 | Boehringer Ingelheim International GmbH | $10,845 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-07 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-07 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-07 | Boehringer Ingelheim International GmbH | $408 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-07 | Boehringer Ingelheim International GmbH | $264 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-07 | Boehringer Ingelheim International GmbH | $72 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-07 | Boehringer Ingelheim International GmbH | $26 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-07 | Boehringer Ingelheim International GmbH | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-07 | Boehringer Ingelheim International GmbH | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-05 | Lilly USA, LLC | $454 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-05 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-04 | Lilly USA, LLC | $894 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-04 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-04 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-03 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-25 | Lilly USA, LLC | $122 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-25 | Lilly USA, LLC | $96 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-25 | Lilly USA, LLC | $58 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-25 | Lilly USA, LLC | $10 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-17 | Lilly USA, LLC | $248 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-02-17 | Lilly USA, LLC | $230 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-02-05 | Lilly USA, LLC | $5,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-31 | Lilly USA, LLC | $383 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-31 | Lilly USA, LLC | $340 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,310 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $426 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $243 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $137 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $85 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $82 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $26 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-23 | Boehringer Ingelheim International GmbH | $26 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-08 | Lilly USA, LLC | $41 | Travel and Lodging | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-01-01 | Novo Nordisk Inc | $1,185 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Wegovy Drug, Obesity | 2025 | |
| 2024-12-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,730 | Consulting Fee | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $140 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $209 | Travel and Lodging | In-kind items and services | 2024 |
The latest 200 records of 1,583.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Westminster, CO, county Jefferson County, CO, state Colorado; placed by its city name.
| Measure | Place (city or town) Westminster, CO | County Jefferson County, CO | State Colorado |
|---|---|---|---|
| Population B01003 | 115,484 | 579,377 | 5,862,189 |
| Population, 2020 census P1 | 116,317 | 582,910 | 5,773,714 |
| Median age B01002 | 37.4 | 40.5 | 37.7 |
| Under 18 B01001 | 19.3% | 18.5% | 21.0% |
| 65 and over B01001 | 15.2% | 17.9% | 15.6% |
| Households B11001 | 48,106 | 241,735 | 2,374,218 |
| Foreign born B05002 | 8.6% | 6.3% | 9.8% |
| Median household income B19013 | $100,272 | $110,656 | $95,470 |
| Median family income B19113 | $126,426 | $138,654 | $119,139 |
| Per capita income B19301 | $53,904 | $60,827 | $52,636 |
| Poverty rate B17001 | 7.3% | 6.7% | 9.4% |
| Unemployment rate B23025 | 3.7% | 3.9% | 4.6% |
| Civilian labor force B23025 | 69,636 | 336,266 | 3,235,476 |
| Mean commute (minutes) B08013 | 27.0 | 26.0 | 25.2 |
| Bachelor's degree or higher B15003 | 44.6% | 52.0% | 45.7% |
| Housing units B25001 | 50,471 | 253,574 | 2,589,053 |
| Owner-occupied B25003 | 61.9% | 70.7% | 66.2% |
| Renters B25003 | 38.1% | 29.3% | 33.8% |
| Median home value B25077 | $532,400 | $637,600 | $539,400 |
| Median gross rent B25064 | $1,882 | $1,861 | $1,761 |
| White, not Hispanic B03002 | 63.9% | 75.2% | 64.8% |
| Black B03002 | 1.1% | 1.1% | 3.8% |
| Hispanic or Latino B03002 | 25.4% | 16.1% | 22.5% |
| Asian B03002 | 4.4% | 2.9% | 3.2% |
| American Indian and Alaska Native B03002 | 0.4% | 0.2% | 0.4% |
Economy now FRED unemployment 4.1% in Sep 2026 (3.8% a year earlier); per capita personal income $86,342 in 2025, up 34% in five years (+7.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Westminster, CO.
Comments